Domain 1: Scope and purpose
| |
Mean percentage domain score = 69.3; SD = 21.3; range 16.7–97.2; % variance = 4.6 | |
1. The overall objective(s) of the guideline is (are) specifically described | 0.594 |
2. The clinical question(s) covered by the guideline is (are) specifically described | 0.768 |
3. The patients to whom the guideline is meant to apply are specifically described | 0.702 |
| |
Domain 2: Stakeholder involvement
| |
Mean percentage domain score = 36.1; SD = 18.9; range 4.2–68.7; % variance = 6.6 | |
4. The guideline development group includes individuals from all the relevant professional groups | 0.643 |
5. The patients’ views and preferences have been sought | 0.580 |
6. The target users of the guideline are clearly defined | 0.683 |
7. The guideline has been piloted among end users | 0.471 |
| |
Domain 3: Rigour of development
| |
Mean percentage domain score = 40.7; SD = 25.0; range 0–89.3; % variance = 42.3 | |
8. The systematic methods were used to search for evidence | 0.794 |
9. The criteria for selecting the evidence are clearly described | 0.763 |
10. The methods used for formulating the recommendations are clearly described | 0.750 |
11. The health benefits, side effects and risks have been considered in formulating the recommendations | 0.689 |
12. There is an explicit link between the recommendations and the supporting evidence | 0.753 |
13. The guideline has been externally reviewed by experts prior to its publication | 0.589 |
14. A procedure for updating the guideline is provided | 0.619 |
| |
Domain 4: Clarity and presentation
| |
Mean percentage domain score = 65.8; SD = 14.1; range 37.5–91.7; % variance = 8.6 | |
15. The recommendations are specific and unambiguous | 0.716 |
16. The different options for management of the condition are clearly presented | 0.589 |
17. Key recommendations are easily identifiable | 0.739 |
18. The guideline is supported with tools for application | 0.640 |
| |
Domain 5: Applicability
| |
Mean percentage domain score = 36.9; SD = 23.2; range 0–91.7; % variance = 6.1 | |
19. The potential organisational barriers in applying the recommendations have been discussed | 0.804 |
20. The potential cost implications of applying the recommendations have been considered | 0.697 |
21. The guideline presents key review criteria for monitoring and/or audit purposes | 0.684 |
| |
Domain 6: Editorial independence
| |
Mean percentage domain score 30.3; SD = 22.4; range 0–72.2 | |
22. The guideline is editorially independent from the funding body | |
23. Conflicts of interest of guideline development members have been recorded | New item |